Filing Analysis
Dyadic International received a Nasdaq deficiency notice on March 27, 2026, for failing to meet the minimum stockholders' equity, market value, or net income requirements. This represents a second active listing deficiency for the company, which is already non-compliant with the $1.00 minimum bid price rule.
Red Flags
- Multiple concurrent Nasdaq listing deficiencies (financial standards and bid price).
- Stock price is below the $1.00 minimum requirement.
- Failure to meet any of the three alternative financial requirements for continued listing.
- Risk of delisting if compliance plans are not accepted or executed successfully.
Key Facts
- Received Nasdaq deficiency notice on March 27, 2026, regarding Rule 5550(b).
- Company failed to maintain $2.5 million in stockholders' equity, $35 million in market value, or $500,000 in net income.
- The company has 45 calendar days (until May 11, 2026) to submit a plan to regain compliance.
- A separate deficiency regarding the $1.00 minimum bid price (Rule 5550(a)(2)) is already active with a June 17, 2026 deadline.
- If a compliance plan is accepted, the company may receive a cure period until September 23, 2026.
Dyadic International, Inc. announced its financial results for the full fiscal year ended December 31, 2025, via a press release on March 25, 2026.
Key Facts
- The filing reports financial results for the fiscal year ended December 31, 2025.
- The report was filed under Item 2.02 (Results of Operations and Financial Condition).
- A press release detailing the results was included as Exhibit 99.1.
- The report was signed by CEO Mark A. Emalfarb on March 25, 2026.
Dyadic International, Inc. entered into an At-The-Market (ATM) Issuance Sales Agreement with Craig-Hallum Capital Group LLC to sell up to $4,237,818 of its common stock. The sales will be made from time to time at prevailing market prices to provide the company with flexible access to capital.
Red Flags
- Potential dilution of existing shareholders as shares are sold into the open market.
Key Facts
- Entered into an ATM Sales Agreement with Craig-Hallum Capital Group LLC on March 6, 2026.
- The company may sell shares of common stock with an aggregate offering price of up to $4,237,818.
- Sales agent will receive a commission of up to 3.0% of gross sales proceeds.
- The offering is conducted under an existing Form S-3 registration statement (File No. 333-273829) effective since August 25, 2023.